Loading...
Loading...

QUAZAR: Oral Azacitidine Maintenance in AML

OncLiveTV
Subscribers 8,880
14

Report Video

Found this content disturbing or inciting religious hatred ? email us along with this video url.

[email protected]

Embed Video

Published on Feb 14, 2020 at 01:02 am

An expert panel discusses the practical implications of the phase III QUAZAR AML-001 Maintenance trial presented by Andrew Wei, MBBS, PhD, at the 2019 ASH meeting and whether these new data will change the standard of care for postremission acute myeloid leukemia.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Loading...

Sitting Alone ?

... Show More